Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
B

Preliminary Results of Phase II Trial of Brentuximab Vedotin and Lenalidomide in Relapsed / Refractory Cutaneous / Peripheral T-Cell Lymphomas

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Basem William
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Basem William
31 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
T-cell Lymphoma
15:48

New Frontline Regimens in Peripheral T-Cell Lymphoma: Brentuximab Ve…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

J. Vose

188 views
16:59

Novel Approaches in Peripheral T-Cell Lymphoma Treatment: Challenges…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

O. O’Connor

38 views
09:35

New Insights into the Molecular Pathogenesis of Peripheral T-Cell Ly…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

P. Gaulard

32 views
07:09

Preliminary Results of Phase II Trial of Brentuximab Vedotin and Len…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

B. William

31 views